← Back to Analyst Consensus 
TGTX Buy
TG THERAPEUTICS, INC.
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (13 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 1, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 7, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Jul 27, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Jul 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 7, 2026 | B of A Securities | maintain | Underperform → Underperform | — | 53% |
| Jul 6, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 27, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 6, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 2, 2026 | JP Morgan | maintain | Overweight → Overweight | $46 | 55% |
| Jan 15, 2026 | Goldman Sachs | maintain | Neutral → Neutral | $39 | 54% |
| Nov 3, 2025 | JP Morgan | maintain | Overweight → Overweight | $49 | 55% |
| Sep 17, 2025 | B. Riley Securities | maintain | Buy → Buy | $55 | 54% |
| Mar 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Jan 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Nov 25, 2024 | JP Morgan | maintain | Overweight → Overweight | $43 | 55% |
| Nov 5, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $55 | 44% |
| Nov 5, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $22 | 54% |
| Oct 29, 2024 | TD Cowen | initiate | — → Buy | $50 | 54% |
| Sep 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $49 | 44% |
| Aug 7, 2024 | B. Riley Securities | maintain | Buy → Buy | $34 | 54% |
| Aug 7, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $20 | 54% |
| Aug 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $49 | 44% |
| May 2, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $49 | 44% |
| May 2, 2024 | Ladenburg Thalmann | maintain | Buy → Buy | $40 | 45% |
| Apr 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| Apr 18, 2024 | JP Morgan | reiterate | Overweight → Overweight | $25 | 55% |
| Apr 18, 2024 | Ladenburg Thalmann | reiterate | Buy → Buy | $39 | 45% |
| Mar 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| Feb 29, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $13 | 54% |
| Feb 28, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| Feb 5, 2024 | B. Riley Securities | maintain | Buy → Buy | $29 | 54% |
| Jan 11, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $45 | 44% |
| Nov 1, 2023 | JP Morgan | maintain | Overweight → Overweight | $23 | 55% |
| Nov 1, 2023 | Jefferies | maintain | Buy → Buy | $0 | 52% |
| Oct 20, 2023 | B. Riley Securities | maintain | Buy → Buy | $24 | 54% |
| Sep 18, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $41 | 44% |
| Aug 7, 2023 | JP Morgan | maintain | Overweight → Overweight | $22 | 55% |
| Aug 3, 2023 | Goldman Sachs | maintain | Neutral → Neutral | $12 | 54% |
| Aug 2, 2023 | B. Riley Securities | maintain | Buy → Buy | $32 | 54% |
| Aug 2, 2023 | Goldman Sachs | upgrade | Sell → Neutral | $12 | 54% |
| Aug 1, 2023 | B. Riley Securities | reiterate | Buy → Buy | $32 | 54% |
| Aug 1, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $41 | 44% |
| Jul 25, 2023 | Goldman Sachs | maintain | Sell → Sell | $16 | 54% |
| Jul 24, 2023 | Goldman Sachs | maintain | Sell → Sell | $16 | 54% |
| Jul 13, 2023 | B. Riley Securities | reiterate | Buy → Buy | $42 | 54% |
| Jun 1, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $34 | 44% |
| May 31, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $34 | 44% |
| May 2, 2023 | Ladenburg Thalmann | maintain | — → Buy | $37.5 | 45% |
| May 1, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $34 | 44% |
| Apr 17, 2023 | Cantor Fitzgerald | reiterate | — → Overweight | $24 | 50% |
Price Target Trend
Apr 30, 2026 Oct 26, 2026
EPS Estimates
0q —
+1y —
0y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days